- Japan
- /
- Food and Staples Retail
- /
- TSE:3088
MatsukiyoCocokara & Co. (TSE:3088) Half-Yearly Results: Here's What Analysts Are Forecasting For This Year
MatsukiyoCocokara & Co. (TSE:3088) last week reported its latest interim results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. MatsukiyoCocokara reported JP¥549b in revenue, roughly in line with analyst forecasts, although statutory earnings per share (EPS) of JP¥34.12 beat expectations, being 4.0% higher than what the analysts expected. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
After the latest results, the twelve analysts covering MatsukiyoCocokara are now predicting revenues of JP¥1.11t in 2026. If met, this would reflect a reasonable 2.1% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to rise 3.3% to JP¥146. Before this earnings report, the analysts had been forecasting revenues of JP¥1.11t and earnings per share (EPS) of JP¥146 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.
View our latest analysis for MatsukiyoCocokara
The analysts reconfirmed their price target of JP¥3,367, showing that the business is executing well and in line with expectations. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values MatsukiyoCocokara at JP¥3,900 per share, while the most bearish prices it at JP¥2,760. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.
Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that MatsukiyoCocokara's revenue growth is expected to slow, with the forecast 4.2% annualised growth rate until the end of 2026 being well below the historical 14% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 3.3% annually. So it's pretty clear that, while MatsukiyoCocokara's revenue growth is expected to slow, it's still expected to grow faster than the industry itself.
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
With that in mind, we wouldn't be too quick to come to a conclusion on MatsukiyoCocokara. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for MatsukiyoCocokara going out to 2028, and you can see them free on our platform here..
Another thing to consider is whether management and directors have been buying or selling stock recently. We provide an overview of all open market stock trades for the last twelve months on our platform, here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:3088
MatsukiyoCocokara
Operates and manages chain stores, drug stores and insurance dispensing pharmacies in Japan.
Flawless balance sheet, good value and pays a dividend.
Similar Companies
Market Insights
Community Narratives


